Global Spinal Muscular Atrophy Medicine Market Research Report 2018

Publisher Name :
Date: 08-Jun-2018
No. of pages: 104
Inquire Before Buying

This report studies the global Spinal Muscular Atrophy Medicine market status and forecast, categorizes the global Spinal Muscular Atrophy Medicine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Spinal Muscular Atrophy Medicine market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report

- Astellas Pharma Inc.

- AveXis, Inc.

- Bioblast Pharma Ltd.

- Cytokinetics, Inc. 24

- F. Hoffmann-La Roche Ltd.

- Genethon

- Genzyme Corporation

- GMP-Orphan SAS

- Ionis Pharmaceuticals, Inc.

- Longevity Biotech, Inc

- Neurodyn Inc.

- Neurotune AG

- Novartis AG

- Sarepta Therapeutics, Inc.

- Voyager Therapeutics, Inc.

- Vybion, Inc.

- WAVE Life Sciences Ltd.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

We can also provide the customized separate regional or country-level reports, for the following regions:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- LMI-070

- ND-602

- NT-1654

- Nusinersen

- NXD-30001

- Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

- Hospital

- Clinic

- Others

The study objectives of this report are:

- To analyze and study the global Spinal Muscular Atrophy Medicine sales, value, status (2013-2017) and forecast (2018-2025).

- Focuses on the key Spinal Muscular Atrophy Medicine manufacturers, to study the sales, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Spinal Muscular Atrophy Medicine are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Spinal Muscular Atrophy Medicine Manufacturers

Spinal Muscular Atrophy Medicine Distributors/Traders/Wholesalers

Spinal Muscular Atrophy Medicine Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Spinal Muscular Atrophy Medicine market, by end-use.

Detailed analysis and profiles of additional market players.

Global Spinal Muscular Atrophy Medicine Market Research Report 2018

Table of Contents
Global Spinal Muscular Atrophy Medicine Market Research Report 2018
1 Spinal Muscular Atrophy Medicine Market Overview
1.1 Product Overview and Scope of Spinal Muscular Atrophy Medicine
1.2 Spinal Muscular Atrophy Medicine Segment by Type (Product Category)
1.2.1 Global Spinal Muscular Atrophy Medicine Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Spinal Muscular Atrophy Medicine Production Market Share by Type (Product Category) in 2017
1.2.3 LMI-070
1.2.4 ND-602
1.2.5 NT-1654
1.2.6 Nusinersen
1.2.7 NXD-30001
1.2.8 Others
1.3 Global Spinal Muscular Atrophy Medicine Segment by Application
1.3.1 Spinal Muscular Atrophy Medicine Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Spinal Muscular Atrophy Medicine Market by Region (2013-2025)
1.4.1 Global Spinal Muscular Atrophy Medicine Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Spinal Muscular Atrophy Medicine (2013-2025)
1.5.1 Global Spinal Muscular Atrophy Medicine Revenue Status and Outlook (2013-2025)
1.5.2 Global Spinal Muscular Atrophy Medicine Capacity, Production Status and Outlook (2013-2025)
2 Global Spinal Muscular Atrophy Medicine Market Competition by Manufacturers
2.1 Global Spinal Muscular Atrophy Medicine Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Spinal Muscular Atrophy Medicine Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Spinal Muscular Atrophy Medicine Production and Share by Manufacturers (2013-2018)
2.2 Global Spinal Muscular Atrophy Medicine Revenue and Share by Manufacturers (2013-2018)
2.3 Global Spinal Muscular Atrophy Medicine Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Spinal Muscular Atrophy Medicine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Spinal Muscular Atrophy Medicine Market Competitive Situation and Trends
2.5.1 Spinal Muscular Atrophy Medicine Market Concentration Rate
2.5.2 Spinal Muscular Atrophy Medicine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Spinal Muscular Atrophy Medicine Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Spinal Muscular Atrophy Medicine Capacity and Market Share by Region (2013-2018)
3.2 Global Spinal Muscular Atrophy Medicine Production and Market Share by Region (2013-2018)
3.3 Global Spinal Muscular Atrophy Medicine Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Spinal Muscular Atrophy Medicine Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Spinal Muscular Atrophy Medicine Consumption by Region (2013-2018)
4.2 North America Spinal Muscular Atrophy Medicine Production, Consumption, Export, Import (2013-2018)
4.3 Europe Spinal Muscular Atrophy Medicine Production, Consumption, Export, Import (2013-2018)
4.4 China Spinal Muscular Atrophy Medicine Production, Consumption, Export, Import (2013-2018)
4.5 Japan Spinal Muscular Atrophy Medicine Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Spinal Muscular Atrophy Medicine Production, Consumption, Export, Import (2013-2018)
4.7 India Spinal Muscular Atrophy Medicine Production, Consumption, Export, Import (2013-2018)
5 Global Spinal Muscular Atrophy Medicine Production, Revenue (Value), Price Trend by Type
5.1 Global Spinal Muscular Atrophy Medicine Production and Market Share by Type (2013-2018)
5.2 Global Spinal Muscular Atrophy Medicine Revenue and Market Share by Type (2013-2018)
5.3 Global Spinal Muscular Atrophy Medicine Price by Type (2013-2018)
5.4 Global Spinal Muscular Atrophy Medicine Production Growth by Type (2013-2018)
6 Global Spinal Muscular Atrophy Medicine Market Analysis by Application
6.1 Global Spinal Muscular Atrophy Medicine Consumption and Market Share by Application (2013-2018)
6.2 Global Spinal Muscular Atrophy Medicine Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Spinal Muscular Atrophy Medicine Manufacturers Profiles/Analysis
7.1 Astellas Pharma Inc.
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 AveXis, Inc.
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 AveXis, Inc. Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Bioblast Pharma Ltd.
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Cytokinetics, Inc. 24
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Genethon
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Genethon Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Genzyme Corporation
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 GMP-Orphan SAS
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Ionis Pharmaceuticals, Inc.
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Longevity Biotech, Inc
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
7.10.4 Main Business/Business Overview
7.11 Neurodyn Inc.
7.12 Neurotune AG
7.13 Novartis AG
7.14 Sarepta Therapeutics, Inc.
7.15 Voyager Therapeutics, Inc.
7.16 Vybion, Inc.
7.17 WAVE Life Sciences Ltd.
8 Spinal Muscular Atrophy Medicine Manufacturing Cost Analysis
8.1 Spinal Muscular Atrophy Medicine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Spinal Muscular Atrophy Medicine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Spinal Muscular Atrophy Medicine Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Spinal Muscular Atrophy Medicine Market Forecast (2018-2025)
12.1 Global Spinal Muscular Atrophy Medicine Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Spinal Muscular Atrophy Medicine Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Spinal Muscular Atrophy Medicine Price and Trend Forecast (2018-2025)
12.2 Global Spinal Muscular Atrophy Medicine Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Spinal Muscular Atrophy Medicine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Spinal Muscular Atrophy Medicine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Spinal Muscular Atrophy Medicine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Spinal Muscular Atrophy Medicine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Spinal Muscular Atrophy Medicine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Spinal Muscular Atrophy Medicine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Spinal Muscular Atrophy Medicine Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Spinal Muscular Atrophy Medicine Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Spinal Muscular Atrophy Medicine
Figure Global Spinal Muscular Atrophy Medicine Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Spinal Muscular Atrophy Medicine Production Market Share by Types (Product Category) in 2017
Figure Product Picture of LMI-070
Table Major Manufacturers of LMI-070
Figure Product Picture of ND-602
Table Major Manufacturers of ND-602
Figure Product Picture of NT-1654
Table Major Manufacturers of NT-1654
Figure Product Picture of Nusinersen
Table Major Manufacturers of Nusinersen
Figure Product Picture of NXD-30001
Table Major Manufacturers of NXD-30001
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) by Applications (2013-2025)
Figure Global Spinal Muscular Atrophy Medicine Consumption Market Share by Applications in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Spinal Muscular Atrophy Medicine Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2013-2025)
Figure North America Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Spinal Muscular Atrophy Medicine Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs) Status and Outlook (2013-2025)
Figure Global Spinal Muscular Atrophy Medicine Major Players Product Capacity (K Pcs) (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Capacity (K Pcs) of Key Manufacturers (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Spinal Muscular Atrophy Medicine Capacity (K Pcs) of Key Manufacturers in 2018
Figure Global Spinal Muscular Atrophy Medicine Major Players Product Production (K Pcs) (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Production (K Pcs) of Key Manufacturers (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Production Share by Manufacturers (2013-2018)
Figure 2017 Spinal Muscular Atrophy Medicine Production Share by Manufacturers
Figure 2017 Spinal Muscular Atrophy Medicine Production Share by Manufacturers
Figure Global Spinal Muscular Atrophy Medicine Major Players Product Revenue (Million USD) (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Spinal Muscular Atrophy Medicine Revenue Share by Manufacturers
Table 2018 Global Spinal Muscular Atrophy Medicine Revenue Share by Manufacturers
Table Global Market Spinal Muscular Atrophy Medicine Average Price (USD/Pcs) of Key Manufacturers (2013-2018)
Figure Global Market Spinal Muscular Atrophy Medicine Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Spinal Muscular Atrophy Medicine Manufacturing Base Distribution and Sales Area
Table Manufacturers Spinal Muscular Atrophy Medicine Product Category
Figure Spinal Muscular Atrophy Medicine Market Share of Top 3 Manufacturers
Figure Spinal Muscular Atrophy Medicine Market Share of Top 5 Manufacturers
Table Global Spinal Muscular Atrophy Medicine Capacity (K Pcs) by Region (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Capacity Market Share by Region (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Capacity Market Share by Region (2013-2018)
Figure 2017 Global Spinal Muscular Atrophy Medicine Capacity Market Share by Region
Table Global Spinal Muscular Atrophy Medicine Production by Region (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Production (K Pcs) by Region (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Production Market Share by Region (2013-2018)
Figure 2017 Global Spinal Muscular Atrophy Medicine Production Market Share by Region
Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) by Region (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Revenue Market Share by Region (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share by Region (2013-2018)
Table 2017 Global Spinal Muscular Atrophy Medicine Revenue Market Share by Region
Figure Global Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs) and Growth Rate (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table North America Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Europe Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table China Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Japan Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table China Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Japan Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) Market by Region (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Consumption Market Share by Region (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Consumption Market Share by Region (2013-2018)
Figure 2017 Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) Market Share by Region
Table North America Spinal Muscular Atrophy Medicine Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Europe Spinal Muscular Atrophy Medicine Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table China Spinal Muscular Atrophy Medicine Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Japan Spinal Muscular Atrophy Medicine Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Southeast Asia Spinal Muscular Atrophy Medicine Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table India Spinal Muscular Atrophy Medicine Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Production (K Pcs) by Type (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Production Share by Type (2013-2018)
Figure Production Market Share of Spinal Muscular Atrophy Medicine by Type (2013-2018)
Figure 2017 Production Market Share of Spinal Muscular Atrophy Medicine by Type
Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) by Type (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Spinal Muscular Atrophy Medicine by Type (2013-2018)
Figure 2017 Revenue Market Share of Spinal Muscular Atrophy Medicine by Type
Table Global Spinal Muscular Atrophy Medicine Price (USD/Pcs) by Type (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Production Growth by Type (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) by Application (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Consumption Market Share by Application (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Consumption Market Share by Applications (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Consumption Market Share by Application in 2017
Table Global Spinal Muscular Atrophy Medicine Consumption Growth Rate by Application (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Consumption Growth Rate by Application (2013-2018)
Table Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (Astellas Pharma Inc.) and Gross Margin (2013-2018)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production Market Share (2013-2018)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018)
Table AveXis, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018)
Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Production Market Share (2013-2018)
Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018)
Table Bioblast Pharma Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018)
Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production Market Share (2013-2018)
Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018)
Table Cytokinetics, Inc. 24 Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018)
Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production Market Share (2013-2018)
Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production Market Share (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018)
Table Genethon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genethon Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genethon Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018)
Figure Genethon Spinal Muscular Atrophy Medicine Production Market Share (2013-2018)
Figure Genethon Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018)
Table Genzyme Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018)
Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Production Market Share (2013-2018)
Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018)
Table GMP-Orphan SAS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018)
Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production Market Share (2013-2018)
Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018)
Table Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018)
Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production Market Share (2013-2018)
Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018)
Table Longevity Biotech, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018)
Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production Market Share (2013-2018)
Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Spinal Muscular Atrophy Medicine
Figure Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine
Figure Spinal Muscular Atrophy Medicine Industrial Chain Analysis
Table Raw Materials Sources of Spinal Muscular Atrophy Medicine Major Manufacturers in 2017
Table Major Buyers of Spinal Muscular Atrophy Medicine
Table Distributors/Traders List
Figure Global Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Price (Million USD) and Trend Forecast (2018-2025)
Table Global Spinal Muscular Atrophy Medicine Production (K Pcs) Forecast by Region (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Production Market Share Forecast by Region (2018-2025)
Table Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) Forecast by Region (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Consumption Market Share Forecast by Region (2018-2025)
Figure North America Spinal Muscular Atrophy Medicine Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure North America Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Spinal Muscular Atrophy Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Europe Spinal Muscular Atrophy Medicine Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Spinal Muscular Atrophy Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure China Spinal Muscular Atrophy Medicine Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Spinal Muscular Atrophy Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Japan Spinal Muscular Atrophy Medicine Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Spinal Muscular Atrophy Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Spinal Muscular Atrophy Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure India Spinal Muscular Atrophy Medicine Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Spinal Muscular Atrophy Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Table Global Spinal Muscular Atrophy Medicine Production (K Pcs) Forecast by Type (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Production (K Pcs) Forecast by Type (2018-2025)
Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Type (2018-2025)
Table Global Spinal Muscular Atrophy Medicine Price Forecast by Type (2018-2025)
Table Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) Forecast by Application (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) Forecast by Application (2018-2025)
Table Researc
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Urinary Incontinence - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 86
    Urinary Incontinence - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H2 2018, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape. Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakag......
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 130
    Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Acute kidney failure occurs when kidneys suddenly become unable to filter waste p......
  • Nocturia - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 33
    Nocturia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H2 2018, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of ......
  • Secondary Hyperparathyroidism - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 38
    Secondary Hyperparathyroidism - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidism - Pipeline Review, H2 2018, provides an overview of the Secondary Hyperparathyroidism (Hormonal Disorders) pipeline landscape. Secondary hyperparathyroidism is occurs when the parathyroid glands in neck produce too much parathyroid hormone (PTH) because calcium levels are too low. ......
  • 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 32
    72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018 Summary 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) pipeline Target constitutes close to 7 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the ......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs